PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
48.82
0.12 (0.25%)
At close: Aug 15, 2025, 3:59 PM
48.92
0.20%
After-hours: Aug 15, 2025, 07:52 PM EDT

PTC Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
629.17M 594.84M -363.3M -453.2M -479.52M -579.22M -626.6M -641.7M -618.05M -571.25M -559.02M -531.39M -555.7M -521.99M -523.9M -454.99M -391.06M -454.12M
Depreciation & Amortization
28.05M 27.49M 75.66M 149.6M 205.17M 249.16M 236.59M 194.75M 167.17M 145.35M 128.84M 108.78M 91.06M 76.86M 64.13M 57.73M 52.79M 89.22M
Stock-Based Compensation
73.6M 74.3M 74.61M 73.88M 110.64M 120.77M 131.21M 142.04M 114.2M 112.56M 110.33M 109.22M 106.43M 104.39M 103.51M 98.69M 89.6M 80.81M
Other Working Capital
-83.38M -72.97M 23.71M -57.89M -5.71M 11.51M -40.15M 65.22M 9.96M 30.62M -1.09M -44.06M 7.53M -14.85M -24.7M -50.32M -48.24M -53.16M
Other Non-Cash Items
101.73M 117.26M 124.66M 130.37M 65M 175.26M 151.32M 74.2M 126.9M 34.04M 48.53M 123.58M 105.65M 92.79M 96.78M 30.68M 34.02M 84.85M
Deferred Income Tax
-55.91M -55.91M -55.91M 3.98M 3.98M -46.93M -46.93M -50.91M -50.91M -4K n/a 377K 22.43M 20.2M 31.93M 37.42M -12.22M -24.21M
Change in Working Capital
-71.87M -66.33M 36.58M -82.61M -20.77M 22.79M -4M 57.52M 13.06M -9.44M -85.33M -70.1M -42.53M -20.84M -23.79M -16.39M 57.86M 10.76M
Operating Cash Flow
704.77M 691.65M -107.69M -177.97M -115.5M -58.17M -158.42M -224.09M -247.62M -288.74M -356.65M -259.53M -272.68M -248.58M -251.33M -246.86M -169.01M -212.67M
Capital Expenditures
44.7M 52.59M -9.23M -31.2M -114.64M -141.3M -120.62M -119.15M -115.97M -114.68M -152.46M -149.5M -149.29M -146.92M -85.33M -80.16M -80.85M -67.39M
Cash Acquisitions
-28.04M n/a n/a -35.89M 15M n/a n/a 35.89M -128.79M -222.78M -144.17M -145.84M 15.95M 104.55M 40.13M 54.32M 57.55M 49.9M
Purchase of Investments
-1.23B -883.39M -669.28M -714.32M -503.46M -325.92M -214.65M -40.88M -55.45M -38.68M -75.55M -124.62M -190.66M -240.22M -543.27M -914.58M -1.47B -1.48B
Sales Maturities Of Investments
704.79M 680.52M 597.74M 452.61M 285.2M 204.53M 156.37M 107.99M 285.42M 363.36M 518.19M 600.14M 594.23M 625.21M 847.78M 937.53M 1.03B 1.11B
Other Investing Acitivies
120.36M 121.49M 122.23M 10.85M 13.04M n/a 2.17M -52.1M 112.58M 206.57M 125.8M 145.84M -15.95M -104.55M -40.13M -54.32M -57.55M -40.89M
Investing Cash Flow
-381.33M -25.25M 44.18M -317.95M -304.87M -262.7M -176.74M -49.88M 116.16M 212.17M 290.18M 326.02M 254.28M 238.08M 219.18M -57.21M -516.13M -430.13M
Debt Repayment
1.49M 1.49M n/a -383.14M -381.85M -381.85M -381.92M 299.73M 148.44M 148.44M 148.72M -151.28M -1.28M -1.28M -2.22M -2.22M 626.02M 606.02M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-22.07M 215.76M 222.1M 1.22B 1.24B 1.02B 1.02B 25.65M 37.04M 22.44M 19.23M 20.66M 13.63M 13.79M 23.1M 58.84M 61.53M 39.15M
Financial Cash Flow
22.21M 264.74M 255.87M 849.88M 870.87M 642.85M 646.4M 328.83M 185.48M 170.88M 167.95M -130.61M 12.36M 12.51M 20.88M 56.61M 696.69M 659.76M
Net Cash Flow
364.53M 931.24M 185.05M 358.37M 444.03M 331.01M 314.33M 60.9M 50.25M 81.92M 98.71M -76.81M -10.6M -2.45M -19.09M -244.15M 18.89M 23.34M
Free Cash Flow
749.48M 744.24M -116.92M -209.17M -230.14M -199.47M -279.04M -343.25M -363.59M -403.42M -509.11M -409.03M -421.96M -395.5M -336.66M -327.02M -249.86M -280.07M